Uroplasty Ramps Up Incontinence Sales Force As Urgent PC Gains More Coverage
This article was originally published in The Gray Sheet
Executive Summary
Uroplasty plans to boost its sales force by roughly 50% by the end of November to seize a growing market for its Urgent PC neuromodulation system following a major payer coverage announcement.
You may also be interested in...
Uroplasty’s Neuromodulator Falls Short On Blue Cross Blue Shield Test
Evidence does not support Uroplasty’s Urgent PC neuromodulation system, a 510(k)-cleared device for treating overactive bladder and symptoms, as an effective treatment option, according to an assessment by the Blue Cross Blue Shield’s Technology Evaluation Center.
News In Brief
FDA Office of Device Evaluation director
CMS News In Brief
Physician imaging cuts finalized